Nonmotor symptoms in a malaysian Parkinson's disease population
- PMID: 24800102
- PMCID: PMC3995174
- DOI: 10.1155/2014/472157
Nonmotor symptoms in a malaysian Parkinson's disease population
Abstract
Background. The nonmotor symptoms are important determinants of health and quality of life in Parkinson's disease but are not well recognized and addressed in clinical practice. This study was conducted to determine the prevalence of nonmotor symptoms and their impact on quality of life in patients with Parkinson's disease. Methods. This was a cross-sectional study among patients with idiopathic Parkinson's disease. Exclusion criteria were a Mini Mental State Examination score of <21/30. Prevalence of nonmotor symptoms was determined using the NMSQuest. The severity of nonmotor symptoms and the quality of life were assessed using validated disease-specific questionnaires (PDQ-39 and NMSS). Results. A total of 113 patients consisting of 60 males and 53 females were recruited. The median duration of illness was 5.0 (2.0-8.0) years. The prevalence rate of nonmotor symptoms in our cohort was 97.3%. The most common reported nonmotor symptom in our cohort was gastrointestinal (76.1%). We found that the severity of the nonmotor symptoms was associated with poorer quality of life scores (r s : 0.727, P < 0.001). Conclusions. Nonmotor symptoms were highly prevalent in our patients with Parkinson's disease and adversely affected the quality of life of our patients. In contrast to western studies, the most common nonmotor symptom is gastrointestinal. The possibility of an Asian diet playing a role in this observation requires further study.
Similar articles
-
Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.J Am Geriatr Soc. 2013 Oct;61(10):1714-21. doi: 10.1111/jgs.12458. Epub 2013 Oct 1. J Am Geriatr Soc. 2013. PMID: 24117286
-
Nonmotor symptoms of 820 Taiwanese patients with Parkinson's disease: an exploratory-comparative study.J Neurol. 2020 May;267(5):1499-1507. doi: 10.1007/s00415-020-09708-4. Epub 2020 Feb 5. J Neurol. 2020. PMID: 32025799
-
Validation of the nonmotor symptoms questionnaire for Parkinson's disease: results from a Chinese pilot study.Int J Neurosci. 2015;125(12):929-35. doi: 10.3109/00207454.2014.986573. Epub 2014 Dec 18. Int J Neurosci. 2015. PMID: 25387070
-
Scales for assessing nonmotor symptom severity changes in Parkinson's disease patients with symptom fluctuations.Int J Neurosci. 2010 Aug;120(8):523-30. doi: 10.3109/00207454.2010.489725. Int J Neurosci. 2010. PMID: 20615055 Review.
-
The impact and management of nonmotor symptoms of Parkinson's disease.Am J Manag Care. 2011 Oct;17 Suppl 12:S308-14. Am J Manag Care. 2011. PMID: 22087551 Review.
Cited by
-
Non-motor Symptoms in Patients with Parkinson's Disease: A Cross-sectional Survey.Cureus. 2018 Oct 4;10(10):e3412. doi: 10.7759/cureus.3412. Cureus. 2018. PMID: 30538900 Free PMC article.
-
Microarray-based Analysis of Differential Gene Expression Profile in Rotenone-induced Parkinson's Disease Zebrafish Model.CNS Neurol Disord Drug Targets. 2024;23(6):761-772. doi: 10.2174/1871527322666230608122552. CNS Neurol Disord Drug Targets. 2024. PMID: 37291778
-
Metallothionein II treatment mitigates rotenone-induced neurodegeneration in zebrafish models of Parkinson's disease.Front Pharmacol. 2025 Jan 31;16:1478013. doi: 10.3389/fphar.2025.1478013. eCollection 2025. Front Pharmacol. 2025. PMID: 39959428 Free PMC article.
-
The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in Taiwan.Neuropsychiatr Dis Treat. 2015 Nov 11;11:2865-73. doi: 10.2147/NDT.S88968. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 26635475 Free PMC article.
-
Nonmotor symptoms and quality of life in Parkinson's disease with different motor subtypes.Z Gerontol Geriatr. 2022 Oct;55(6):496-501. doi: 10.1007/s00391-021-01950-3. Epub 2021 Aug 10. Z Gerontol Geriatr. 2022. PMID: 34374861 English.
References
-
- Lim S, Lang AE. The nonmotor symptoms of Parkinson’s disease: an overview. Movement Disorders. 2010;25(supplement 1):S123–S130. - PubMed
-
- Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbity of the nonmotor symptoms of Parkinson’s disease. Movement Disorders. 2001;16(3):507–510. - PubMed
-
- Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson’s disease: a community-based study. Archives of Neurology. 1996;53(2):175–179. - PubMed
-
- Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older, men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology. 1996;46(2):388–393. - PubMed
-
- Abbott RD, Ross GW, White LR, et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology. 2005;65(9):1442–1446. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources